title: [Prevalence and socio-economic relevance of allergies in Germany].
abstract: Within the last five decades, the worldwide prevalence of allergic diseases such as asthma, hay fever, or food allergies has increased dramatically. Germany follows a similar trend; several studies have shown increased numbers of allergic diseases in this period. Although allergic diseases do not exhibit high mortality rates, the loss of quality of life as shown by studies conducted by the World Health Organization (WHO) is considerable. Additional health-economical analyses documented that allergic patients more frequently occupy services of the health care system in Germany. The treatment of allergies and the increasing consultation rates cause rising costs and an increasing burden for the national economy. Currently it is possible to control allergic diseases such as asthma by a precise diagnosis or identification of the causative allergen. However, a considerable reduction in the prevalence of allergic disease and its therapy costs can only be expected if causative therapies and effective prevention strategies are available.
authors.affiliation: Institut für Laboratoriumsmedizin, Pathobiochemie und Molekulare Diagnostik, Philipps-Universität Marburg, Universitätsklinikum Gießen und Marburg GmbH, Baldingerstr., 35043, Marburg, Deutschland.
authors.forename: C
authors.initials: C
authors.lastname: Böcking
authors.forename: H
authors.initials: H
authors.lastname: Renz
authors.forename: P I
authors.initials: PI
authors.lastname: Pfefferle
mesh_terms: D003430:Cross-Sectional Studies; D005544:Forecasting; D005858:Germany; D017048:Health Care Costs / Q000639:trends*; D006801:Humans; D006967:Hypersensitivity / Q000191:economics* / Q000453:epidemiology* / Q000628:therapy; D009313:National Health Programs / Q000191:economics*; D012017:Referral and Consultation / Q000191:economics / Q000706:statistics & numerical data; D014600:Utilization Review